Method for extracting and purifying azaspiroring acid-2 standard substance from marine dinoflagellate culture solution
Through multi-step extraction and separation technology, high-purity azaspiroic acid-2 standard substance was prepared from marine dinoflagellate culture medium, solving the problem of shortage of AZA-2 standard substances in the prior art and supporting toxicological research and food safety testing.
Patent Information
- Application Number
- CN202411007753.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-12
AI Technical Summary
The lack of high-purity azaspiroic acid-2 (AZA-2) standard substances in the prior art has led to slow progress in toxicology research, and due to insufficient quality, it is difficult to ensure shellfish food safety and marine environmental risk assessment.
Extract and separate purify nitrocyclic acid-2 from marine dinoflagellate culture medium, and prepare the multi-step method of liquid-liquid extraction, dextran gel chromatography, semi-preparation liquid chromatography and solid-phase extraction columns. High-purity AZA-2 standard substances can have a purity of up to 95%, and are quality inspection through high-resolution mass spectrometry and nuclear magnetic resonance technology.
The preparation of AZA-2 standard substances with high purity, uniformity and stability has alleviated the shortage of domestic commercial standard substances, and supported the toxicological research and food safety testing of AZA toxins.
Smart Images

Figure CN118930563A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for preparing an azaspirocyclic acid-2 standard substance, and in particular to a method for separating and preparing a high-purity azaspirocyclic acid standard substance from marine microalgae Azadinium poporum, and belongs to the technical field of natural product separation. Background Art
[0002] Azaspiracid (AZA) is a class of fat-soluble polyether compounds produced by marine toxic microalgae. It has a unique spiral ring structure and more than 60 homologues have been discovered. Among them, azaspiracid-2 (AZA-2) is the most toxic component of this toxin, with a chemical formula of C 48 H 73 NO 12 (like Figure 1 (as shown), mainly produced by A. spinosum and A. poporum. After eating shellfish contaminated with AZA, people will experience poisoning symptoms such as nausea, vomiting, diarrhea and gastrointestinal cramps. Since these symptoms are similar to those of typical diarrheal shellfish poisoning (DSP) and bacterial diarrhea, they are often misjudged or ignored. In recent years, AZA has been frequently detected in shellfish samples collected from coastal waters in many parts of the world, and has caused many human poisoning incidents. Studies have shown that AZA is cytotoxic to a variety of cells, and the cytotoxic effects of AZA-1 and AZA-2 are irreversible. They mainly cause cell death by destroying cell membrane structure, blocking DNA synthesis, destroying Golgi apparatus, and changing the cytoskeleton. However, due to the lack of AZA standard substances, the toxicological research of AZA has been slow, and its toxic mechanism to the human body is still unclear.
[0003] The research on AZA toxin separation and preparation technology can solve the problem of shortage of AZA standard materials in China to a certain extent, which has significant economic and social benefits. At the same time, it lays the foundation for toxicological research on AZA toxin, shellfish food safety testing, marine environmental risk assessment and other work. Summary of the invention
[0004] The technical problem to be solved by the present invention is to provide a method for preparing an azaspirocyclic acid-2 (AZA-2) standard substance in view of the deficiencies in the prior art, that is, to provide a method for extracting and purifying an azaspirocyclic acid-2 (AZA-2) standard substance from a marine dinoflagellate culture solution. The method of the present invention can prepare a high-purity AZA-2 standard substance, and the purity of the prepared AZA-2 standard substance can reach 95%. It has good uniformity and stability, and is comparable to the quality of similar products currently commercialized internationally, thereby alleviating the problem of the lack of domestic commercial AZA-2 standard substances to a certain extent.
[0005] In order to achieve the above object, the present invention adopts the following technical solution:
[0006] The present invention first provides a method for extracting and purifying azaspironic acid-2 (AZA-2) standard substance from a marine dinoflagellate culture fluid, comprising the steps of using an organic reagent to break algal cells in the collected toxin-producing algae culture fluid, then using an extractant to obtain an organic phase containing AZA toxin by liquid-liquid extraction, concentrating and re-dissolving the organic phase to obtain a crude AZA toxin extract, and then performing preliminary separation and purification of the crude AZA toxin extract on a dextran gel chromatography column to remove most of the pigment impurities, and then further separating and purifying the extract using semi-preparative liquid chromatography, and finally enriching and purifying the extract using a solid phase extraction column (SPE) and concentrating and re-dissolving the extract to obtain the AZA-2 standard substance.
[0007] In the above technical solution, the method described specifically comprises the following steps:
[0008] (1) Preparation of AZA toxin crude extract:
[0009] The cell culture fluid of toxin-producing algae for preparing AZA-2 standard substance is collected, a small amount of organic reagent is added to break the algal cells to release the toxin into the culture fluid, and after standing and filtering, the AZA toxin is extracted by liquid-liquid extraction using an extractant, the lower organic phase is collected and filtered, and then the extractant in the organic phase is removed by rotary evaporation, and then re-dissolved with methanol to obtain a crude AZA toxin extract;
[0010] (2) Separation and purification of AZA-2 standard substance:
[0011] The crude extract of AZA toxin obtained in step (1) is loaded into an activated dextran gel chromatography column, eluted with a methanol solution, the eluate is collected in sections, and the components containing AZA-2 are selected for merging and concentration; then, semi-preparative liquid chromatography is used for further purification, components are collected according to the peak time of the target substance, and the eluted components containing AZA-2 are combined; finally, a solid phase extraction column (SPE column) is used for enrichment and purification, eluted with 20% methanol to remove the salt matrix in the sample, and then eluted with a methanol solution; the collected components are used to remove the solvent using a rotary evaporator, and re-dissolved with methanol to obtain the AZA-2 standard substance.
[0012] In the above technical scheme, in step (1), the toxin-producing algae used to prepare the AZA-2 standard substance is Cycloamine gastropoda; the cell disruption is performed using an organic reagent, and the mixture is magnetically stirred at a speed of 2000 to 3000 rpm during disruption, and the stirring time is 15 to 30 minutes; the organic reagent is acetone, and the volume of acetone added is 5 to 7% of the volume of the toxin-producing algae culture solution.
[0013] In the above technical solution, in step (1), the standing time is 12 to 24 hours; the filtration after standing is performed by using a flat filter covered with an 8 μm mixed fiber filter membrane.
[0014] In the above technical solution, in step (1), the extraction reagent is dichloromethane, and the added volume ratio of dichloromethane is 4-6% of the volume of the toxic algae culture solution.
[0015] In the above technical scheme, in step (1), the organic phase is filtered using a 0.22 μm nylon filter membrane; the rotary evaporation is performed under the following operating conditions: temperature 30-45°C, pressure 0.05-0.2 MPa, and evaporation to dryness; the methanol re-dissolution refers to the algae cell culture fluid being crushed, allowed to stand, filtered, and 10-20 L of filtrate is taken, the filtrate is extracted, and the product obtained by rotary evaporation is re-dissolved with 5-10 mL of pure methanol.
[0016] In the above technical scheme, in step (2), the filler of the dextran gel chromatography column is Sephadex LH-20 gel, which is activated by soaking in chromatographic pure methanol overnight and packed into a 16mm×700mm chromatography column by wet packing; the crude AZA toxin extract has a column volume of 3 to 5 mL.
[0017] In the above technical scheme, in step (2), pure methanol is used for elution, the elution volume is 200-250 mL, the elution flow rate is 0.5-2 mL / min, the eluent of the first 20-40 min is discarded, and then 0.5-2 mL is collected per minute, and 200-250 mL is continuously collected to select the components containing AZA-2 for merging, and concentrated to 3-5 mL using a rotary evaporator. The operating conditions of the rotary evaporation are: temperature 30-45°C, pressure 0.05-0.2 MPa.
[0018] In the above technical scheme, in step (2), the semi-preparative liquid chromatography is performed using a Waters X-BridgeC18 OBD semi-preparative column, the mobile phase A is ultrapure water containing 0.05% (mass concentration) formic acid, the mobile phase B is methanol, and the elution is performed in an isocratic elution manner. The volume percentage of the mobile phase A is 20-28%, the volume percentage of the mobile phase B is 72-80%, the flow rate is 3-5 mL / min, and the eluate eluted for 18-22 minutes is collected, and the elution components containing AZA-2 are combined.
[0019] In the above technical scheme, in step (2), the solid phase extraction column (SPE column) is a Waters Oasis-HLB column. The elution component containing AZA-2 is enriched and purified by the solid phase extraction column, and then eluted with 20% methanol by mass to remove the salt matrix in the sample. The amount of 20% methanol solution used during elution is 3 to 5 mL, and the elution time is 6 to 10 min. After the elution is completed, methanol is used for elution again, the elution volume is 3 to 5 mL, and the flow rate during elution is 0.5 to 1 mL / min.
[0020] In the above technical scheme, in step (2), the collected components are used to remove the solvent using a rotary evaporator, and the operating conditions are: temperature 30-45°C, pressure 0.05-0.2MPa, and evaporation to dryness; the AZA-2 standard substance is obtained by re-dissolving it with methanol, and the methanol re-dissolution is performed by separating, purifying, and rotary evaporating 3-5mL of AZA toxin crude extract and re-dissolving the product with 3-5mL of methanol.
[0021] In the above technical scheme, after the AZA-2 standard substance is prepared, the purity, uniformity and stability of the AZA-2 standard substance sample are evaluated and tested: the secondary mass spectrum of the AZA-2 standard substance sample is obtained by high-resolution mass spectrometry technology (LC-HRMS / MS), and the prepared sample is subjected to preliminary qualitative analysis; then, the nuclear magnetic resonance hydrogen spectrum of the sample is obtained by quantitative nuclear magnetic resonance technology, and the purity of the AZA-2 standard substance sample is obtained; finally, the uniformity and stability of the AZA-2 standard substance sample are tested according to the requirements of the national metrology technical specifications.
[0022] In the above technical solution, the quantitative nuclear magnetic resonance technology adopts the external standard method for detection, and the external standard substance is caffeine.
[0023] The method of the present invention uses Cycloamine gastropoda as the source of AZA toxin, uses acetone to break up the toxin-producing algae cells, and releases the toxin into the culture medium; then the toxin is directly extracted from the culture medium by liquid-liquid extraction, which can effectively improve the recovery efficiency of the toxin. The extracted sample is purified by multi-step chromatography separation technology to obtain the AZA-2 standard substance, and the quality of the AZA-2 standard substance is inspected. The purity of the AZA-2 standard substance prepared by the method of the present invention is as high as 95%, the sample is uniform, and has good stability, which is comparable to the quality of similar products currently commercialized internationally. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 : Chemical structure diagram of azaspirocyclic acid-2 standard substance, i.e., AZA-2;
[0025] Figure 2 : Screening Example 1 after using different concentrations of acetone to treat the culture solution of Cycloamine spp. to recover the AZA toxin;
[0026] Figure 3 : The effects of different dichloromethane dosages on the recovery rate of AZA toxin liquid-liquid extraction in Screening Example 2, different letters indicate significant differences among the groups (p<0.05);
[0027] Figure 4 : Screening of the distribution of AZA-2 in the Sephadex chromatography column with different eluent volumes in Example 3 (● represents AZA-2);
[0028] Figure 5 : High resolution secondary mass spectrum of the purified AZA-2 standard substance in Example 1;
[0029] Figure 6 : H NMR spectrum of the purified AZA-2 standard substance in Example 1;
[0030] Figure 7 : The uniformity of the AZA-2 standard substance obtained in Example 1 was randomly selected;
[0031] Figures 8a to 8d : The short-term stability of AZA-2 standard substance under different temperature conditions in Example 1 (wherein, Figure 8a This is the stability diagram at -80°C; Figure 8b This is the stability diagram at -20°C; Figure 8c This is the stability diagram at 20°C; Figure 8d is the stability diagram at 4°C). DETAILED DESCRIPTION
[0032] The technical solution of the present invention is further described in detail below in conjunction with the accompanying drawings and specific embodiments. However, the protection scope of the present invention is not limited to the scope covered by the embodiments, but is defined by the claims.
[0033] Screening Example 1: Screening of acetone concentration when extracting AZA toxin from large-scale culture fluid
[0034] Large-scale toxin-producing algae cell disruption: The algae cells were disrupted by adding acetone to the cells of the toxin-producing algae (Cycloamine ventralis), and then the mixture was magnetically stirred at a speed of 2400rpm for 15min, and the amount of acetone added was optimized to achieve the best disruption effect: a control group (without acetone), a 3% acetone (v / v) treatment group, and a 7% acetone (v / v) treatment group were set up, and 3 parallels were set up for each group. The control group directly extracted the toxins, and the acetone treatment group was left to stand for 24h before extracting the toxins. Because the samples needed to be analyzed by liquid chromatography-mass spectrometry, they were filtered through a 0.22μm nylon membrane in a 1.5mL sample bottle and stored at -18℃ for LC-MS / MS analysis.
[0035] The toxin recovery rates of Cycloamine in different experimental groups are as follows Figure 2 As shown. The recovery rate of AZA-2 in the control group was only 28%. Microscopic examination revealed that there were still a large number of intact algal cells in the algal solution, indicating that the toxin extraction efficiency was low without disruption. After treatment with 3% acetone, the recovery rate of AZA-2 increased to 45%, but some algal cells were still not completely disrupted; after treatment with 7% acetone, the recovery rate of AZA-2 could reach 84%. Therefore, it was finally determined that 7% acetone (v / v) was used to disrupt the algal cells of Cycloamine gastropoda.
[0036] Screening Example 2: Screening of dichloromethane dosage when extracting AZA toxin
[0037] Optimization of liquid-liquid extraction method of toxins in culture medium: Liquid-liquid extraction of toxins in culture medium was performed using dichloromethane, and the amount of extractant was optimized: First, 7% acetone (v / v) was added to the culture medium to break the cells of Cycloamine gastropoda, and then the mixture was magnetically stirred at a speed of 2400rpm for 15min. After standing for 24h, the algal cell residues and suspended particles were filtered using a flat filter covered with an 8μm mixed fiber filter membrane. 10mL of the filtrate was enriched through an SPE column to determine the initial content of toxins in the experimental system. Then 300mL of the filtrate was taken and 3, 4, 5, 6 and 7% dichloromethane (9, 12, 15, 18 and 21mL) were added respectively for liquid-liquid extraction. The lower organic phase was collected, and the prepared sample was filtered through a 0.22μm nylon filter membrane in a 1.5mL sample bottle and stored at -18℃ for LC-MS / MS analysis.
[0038] Effects of different dichloromethane dosages on toxin recovery rates Figure 3 As shown. The results showed that the recovery rate of AZA-2 increased with the increase of dichloromethane dosage and finally stabilized. There was no significant difference in the extraction recovery rate of AZA-2 when the dosage was 5, 6 and 7% (p>0.05). When the amount of dichloromethane added was 5%, the recovery rate of AZA-2 reached 72.0±1.9%. Taking into account the extraction efficiency and reagent dosage, 5% (v / v) dichloromethane was finally added to the filtrate of Cycloamine algae for liquid-liquid extraction.
[0039] Screening Example 3: Optimization of Chromatographic Column Purification Method
[0040] Screening of elution volume when using a dextran gel chromatography column for purification: Use Sephadex LH-20 (Cytiva, USA) dextran gel to fill a 16mm×700mm chromatography column, weigh 15g of dextran gel, soak it in chromatographic grade methanol overnight to allow the gel to fully swell, and remove some alcohol-soluble impurities, and use a wet column packing method to fill it. After 5mL of AZA toxin was crudely extracted and loaded onto the column, it was eluted with 200mL of methanol at a flow rate of 1mL / min. The eluate of the first 40min was discarded, and then the column was collected in sections, collecting 1 tube per minute, 1mL in each tube, and 200 tubes were collected continuously. 0.5mL was taken from each tube and flow injection analysis (FIA) was performed using LC-MS / MS. The results showed that the elution volume of the toxin was in the range of 95-110mL (such as Figure 4 The toxin-containing fractions were combined and concentrated to 5 mL using a rotary evaporator for further purification.
[0041] Screening Example 4: Optimization of Semi-preparative Liquid Chromatography Purification Method
[0042] Screening of toxin collection time during semi-preparative liquid chromatography purification: The sample purified by the dextran gel chromatography column was further separated and purified by a semi-preparative liquid chromatograph (HITACHI, Japan, or other similar instruments). The chromatographic column used a Waters X-Bridge C18OBD semi-preparative column (250×10mm, 5μm), the mobile phase A was ultrapure water containing 0.05% formic acid, the mobile phase B was methanol, and the elution was performed by isocratic elution with a flow rate of 4.0mL / min. The detector was a diode array detector (DAD) with a detection wavelength of 210nm. The eluate was collected every minute, and the toxin content was determined by mass spectrometry. The results showed that when the mobile phase B was 76%, the toxin was eluted at 19 to 20 minutes, and the elution time was 2 to 3 minutes. The toxins at 20 to 21 minutes were collected and combined, and finally enriched and purified using an SPE column to obtain the AZA-2 standard substance.
[0043] After screening out the best parameters, a specific embodiment is carried out. The present invention is described below in conjunction with the specific embodiment:
[0044] Embodiment 1:
[0045] An azaspirocyclic acid-2 (AZA-2) standard substance is prepared by the following method:
[0046] (1) Preparation of AZA toxin crude extract:
[0047] Acetone was added to the cycloamine algae at a rate of 7% (v / v), the algae cells were broken, and then the mixture was magnetically stirred at a speed of 2400rpm for 15min to fully release the toxin into the culture medium; after standing for 24h, it was filtered using a flat filter covered with an 8μm mixed fiber filter membrane. 10L of the filtrate was taken, and 500mL of dichloromethane (dichloromethane added at a rate of 5% v / v) was added for liquid-liquid extraction; the lower organic phase was collected, and the extractant in the organic phase was removed by rotary evaporation, and the operating conditions of the rotary evaporation were: temperature 30°C, pressure 0.05MPa, and evaporation to dryness; then 5mL of methanol was added for re-dissolution to obtain the AZA toxin crude extract.
[0048] (2) Separation and purification of AZA-2 standard substance:
[0049] Sephadex LH-20 (Cytiva, USA) dextran gel was used to fill a 16mm×700mm chromatography column. 15g of dextran gel was weighed and soaked in chromatographic grade methanol overnight to fully swell the gel and remove some alcohol-soluble impurities. The column was filled by wet packing. After 5mL of AZA toxin crude extract was loaded on the column, 200mL of methanol was used for elution at a flow rate of 1mL / min. The eluate of the first 40min was discarded, and then the eluate was collected in sections, with 1 tube collected per minute and 1mL collected in each tube, and 200 tubes were collected continuously; the components containing toxins were combined and concentrated to 5mL using a rotary evaporator for further purification.
[0050] The sample purified by the dextran gel chromatography column was further separated and purified by a semi-preparative liquid chromatograph (HITACHI, Japan, or other similar instruments). The chromatographic column used was a Waters X-Bridge C18 OBD semi-preparative column (250×10mm, 5μm), the mobile phase A was ultrapure water containing 0.05% formic acid, the mobile phase B was methanol, the volume fraction of mobile phase B was 76%, and the volume fraction of mobile phase A was 24%. The elution was performed by isocratic elution, the flow rate was 4.0mL / min, the detector was a diode array detector (DAD), and the detection wavelength was 210nm. The eluent was collected every minute, the toxin was eluted at 19 to 20 minutes, the elution time was 2 minutes, and the toxins at 20 to 21 minutes were collected and combined.
[0051] Finally, a Waters Oasis-HLB column was used for enrichment and purification. After enrichment and purification, 20% methanol by mass was used for elution to remove the salt matrix in the sample. The amount of 20% methanol solution used for elution was 5 mL, and the elution time was 10 min. After elution, methanol was used for elution. The volume during elution was 5 mL, and the flow rate during elution was 0.5 mL / min. The collected components were removed from the solvent using a rotary evaporator. The operating conditions were: temperature 40°C, pressure 0.1 MPa, and evaporation to dryness. After re-dissolving with 3 mL of methanol, the AZA-2 standard substance was obtained.
[0052] Verification Example: Quality Verification of AZA-2 Reference Material
[0053] (1) Purity evaluation
[0054] The AZA-2 standard substance obtained in Example 1 was subjected to full scan (Full MS) and secondary daughter ion scan (dd-MS) detection using LC-HRMS / MS. A heated electrospray ion source (ESI) was used in positive ion mode, the Full MS acquisition range was 250-1500 m / z, the Full MS resolution was 70000 FWHM, and the dd-MS resolution was 17500 FWHM. A KinetexXB-C18 column was used for separation, the column temperature was 40°C, the flow rate was 0.35 mL / min, and the injection volume was 5 μL. Mobile phase A was excess water, and mobile phase B was 95% acetonitrile aqueous solution, both containing 2 mM ammonium formate and 50 mM formic acid.
[0055] NMR detection was performed using a nuclear magnetic resonance spectrometer (Bruker AVANCE III, 600MHz) with an ultra-low temperature probe, and caffeine was used as an external standard for quantitative analysis. 700 μL of deuterated methanol was added to the sample to redissolve the sample, and then 600 μL was added to the NMR tube for NMR testing. Preparation of caffeine standard substance: The caffeine standard substance was weighed using an ultra-micro electronic balance (0.001 mg) and the accurate mass m was recorded. std , placed in a 4mL glass injection bottle, add 700μL deuterated methanol to completely dissolve the sample, then take 600μL and add it to the NMR tube for NMR testing. NMR parameters: sample temperature: 25.0±0.5℃; spectral width: 7507.5Hz, 15.0ppm; flip angle: 90°; acquisition time: 2.18s; relaxation delay time: 11s; number of scans: 64 times.
[0056] It can be seen from the high-resolution secondary mass spectrometry that the secondary fragment ions of the AZA-2 standard substance prepared in the present invention are consistent with the fragment ions of the primary standard substance provided by the Canadian NRC (e.g. Figure 5 The prepared AZA-2 standard samples were combined and subjected to quantitative H NMR spectrum test to obtain its H NMR spectrum (as shown in FIG. Figure 6 As shown). No obvious impurity peaks were found in the spectrum, and the chemical shift of the peaks was consistent with that reported in the existing literature, so it can be determined that the prepared sample is AZA-2. Finally, the purity of the sample was tested using quantitative nuclear magnetic resonance technology. The purity of the AZA-2 standard substance was calculated to be 95% through the quantitative peak of the 8-Me group in the AZA-2 structure and the quantitative peak of the caffeine standard.
[0057] (2) Uniformity test
[0058] Dissolve the purified AZA-2 standard in methanol, mix thoroughly and dispense into 2 mL brown vials, seal the vials with capping pliers and store at -80°C. Randomly select 10 vials (total number of units ≤ 500) and test their concentrations by LC-MS / MS. Repeat the test for each sample 3 times. Perform a homogeneity test on the AZA-2 standard substance in accordance with the requirements of the national metrology technical specification JJF 1343-2012. The specific evaluation method is as follows:
[0059] m units were randomly selected from the total units of the standard substance, and the variance analysis method (F test method) was selected to compare the variance between groups and the variance within groups to determine whether there was a systematic deviation between the measurements of each group. Each packaging unit was repeated n times to calculate the variance between and within groups.
[0060] According to the national standard material measurement specification, the homogeneity of the AZA-2 standard material developed in this study was evaluated. This batch of AZA-2 standard material was packaged into 120 bottles, from which 10 bottles (total number of units ≤ 500) were randomly selected for quantitative analysis using LC-MS / MS. Each bottle was measured three times. The results are shown in Table 1. The relative observed values of the randomly selected samples were between 0.9 and 1.1 (e.g. Figure 7 ), indicating that the sample was uniform between bottles.
[0061] Table 1 Concentration values of 10 bottles of AZA-2 standard substances randomly selected (ng mL -1 )
[0062] Sample No. 1 2 3 average value <![CDATA[s 2 ]]> 1 854.95 804.10 784.17 814.41 29.80 2 846.22 822.94 801.00 823.39 18.46 3 864.43 858.98 845.80 856.40 7.82 4 792.52 898.29 858.90 849.90 43.65 5 867.52 882.31 864.83 871.56 7.69 6 872.35 890.19 872.17 878.24 8.45 7 898.00 862.35 865.82 875.39 16.05 8 887.69 837.67 865.13 863.50 20.45 9 798.56 843.24 857.02 832.94 24.96 10 803.70 860.65 872.96 845.77 30.17
[0063] The results of the one-way ANOVA analysis based on the uniformity statistical analysis method are shown in Table 2, with a statistic of F = 1.77 <F 0.05 (9,20)=2.39, that is, F <F 0.05 (9,20), it is considered that the content of AZA-2 in the sample has no significant difference between bottles and within bottles, so the sample is uniform.
[0064] Table 2 Results of variance analysis for homogeneity test of AZA-2 standard material
[0065]
[0066]
[0067] (3) Stability test
[0068] Four temperatures were set at -80, -20, 4 and 20°C to test the short-term stability (30 days) of the samples. The packaged AZA-2 standard substance was placed under the set temperature conditions, and the sampling time points were designed according to the principle of dense first and sparse later. Three bottles were randomly selected for toxin content analysis at 0, 2, 4, 8, 16 and 30 days. The stability of the AZA-2 standard substance was statistically tested based on the classical linear model recommended by the National Metrology Technical Specifications (JJF1343-2012). The test results were checked by t-test to see if they were within the statistically allowed uncertainty range, that is, with time as the X-axis and Y representing the characteristic value of the standard substance, a straight line was fitted, and the absolute value of the slope and the product of the slope standard deviation and the t factor were compared to determine whether the sample content had changed significantly.
[0069] The short-term stability results of AZA-2 standard substance under four different temperature conditions are shown in FIG8 . In the short-term stability test results under all temperature conditions, |β1| < s(β1)*t, indicating that the slope is not significant (Table 3), that is, the sample is stable, and the toxin can meet the short-term stability requirements under the storage conditions. The above results show that the AZA-2 standard substance prepared by the present invention has good short-term stability and can meet the long-distance transportation requirements at 20°C.
[0070] Table 3 Short-term stability test results of AZA-2 standard substance under different temperature conditions
[0071]
[0072] The present invention provides a method for preparing AZA-2 standard substance from large-scale marine dinoflagellate culture fluid, optimizes the extraction, separation and purification methods of AZA-2, has simple operation steps, and can be applied to the extraction and purification of toxins in large-scale culture fluid. At the same time, the quality of the prepared AZA-2 standard substance is identified, and its purity can reach 95%, and it has good uniformity and stability, which can meet the application requirements of secondary standard substances. The method will provide an important reference for the grading and identification of AZA-2 standard substances.
[0073] The above examples are only for illustrating the technical concept and technical features of the present invention, and cannot be used to limit the protection scope of the present invention. Any equivalent transformation or modification made according to the essence of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for extracting and purifying azaspirocyclic acid-2 standard substance from marine dinoflagellate culture fluid, characterized in that: The collected toxin-producing algae culture fluid is used to break the algae cells with an organic reagent, and then an organic phase containing AZA toxin is obtained by liquid-liquid extraction using an extractant. The organic phase is concentrated and re-dissolved to obtain a crude AZA toxin extract. The crude AZA toxin extract is then subjected to preliminary separation and purification on a dextran gel chromatography column to remove most of the pigment impurities, and then further separated and purified using semi-preparative liquid chromatography. Finally, a solid phase extraction column (SPE) is used for enrichment and purification and the AZA-2 standard substance is obtained after concentration and re-dissolution.
2. The method according to claim 1, characterized in that The method specifically comprises the following steps: (1) Preparation of AZA toxin crude extract: The cell culture fluid of toxin-producing algae for preparing AZA-2 standard substance is collected, a small amount of organic reagent is added to break the algal cells to release the toxin into the culture fluid, and after standing and filtering, the AZA toxin is extracted by liquid-liquid extraction using an extractant, the lower organic phase is collected and filtered, and then the extractant in the organic phase is removed by rotary evaporation, and then re-dissolved with methanol to obtain a crude AZA toxin extract; (2) Separation and purification of AZA-2 standard substance: The crude extract of AZA toxin obtained in step (1) is loaded into an activated dextran gel chromatography column, eluted with a methanol solution, the eluate is collected in sections, and the components containing AZA-2 are selected for merging and concentration; then, semi-preparative liquid chromatography is used for further purification, components are collected according to the peak time of the target substance, and the eluted components containing AZA-2 are combined; finally, a solid phase extraction column (SPE column) is used for enrichment and purification, eluted with 20% methanol to remove the salt matrix in the sample, and then eluted with a methanol solution; the collected components are used to remove the solvent using a rotary evaporator, and re-dissolved with methanol to obtain the AZA-2 standard substance.
3. The preparation method according to claim 2, characterized in that: After the AZA-2 standard substance is prepared, the purity, uniformity and stability of the AZA-2 standard substance sample are evaluated and tested: the secondary mass spectrum of the AZA-2 standard substance sample is obtained by high-resolution mass spectrometry technology (LC-HRMS / MS), and a preliminary qualitative analysis is performed on the prepared sample; then, the nuclear magnetic resonance hydrogen spectrum of the sample is obtained by quantitative nuclear magnetic resonance technology, and the purity of the AZA-2 standard substance sample is obtained; finally, the uniformity and stability of the AZA-2 standard substance sample are tested according to the requirements of the national metrology technical specifications.
4. The preparation method according to claim 2, characterized in that: In step (1), the toxic algae used to prepare the AZA-2 standard substance is Cycloamine gastropoda; the organic reagent is acetone, and the volume of acetone added is 5-7% of the volume of the toxic algae culture solution.
5. The preparation method according to claim 2, characterized in that: In step (1), the extraction reagent is dichloromethane, and the added volume ratio of dichloromethane is 4-6% of the volume of the toxic algae culture solution.
6. The preparation method according to claim 2, characterized in that: In step (2), the dextran gel chromatography column is filled with Sephadex LH-20 gel, and methanol is used for elution. The elution flow rate is 0.5-2 mL / min, and the eluent of the first 20-40 min is discarded. Thereafter, 0.5-2 mL is collected per minute, and 200-250 mL is continuously collected to select the components containing AZA-2 for merging and concentration.
7. The preparation method according to claim 2, characterized in that: In step (2), the semi-preparative liquid chromatography is performed using a Waters X-Bridge C18 OBD semi-preparative column, mobile phase A is ultrapure water containing 0.05% formic acid, mobile phase B is methanol, and elution is performed in an isocratic elution manner. The volume percentage of mobile phase A is 20-28%, and the volume percentage of mobile phase B is 72-80%. The eluate eluted for 18-22 minutes is collected and the elution components containing AZA-2 are combined to obtain.
8. The preparation method according to claim 2, characterized in that: In step (2), the solid phase extraction column is a Waters Oasis-HLB column, which is eluted with 20% methanol solution to remove the salt matrix in the sample, and then eluted with methanol. The eluate is used to remove the solvent using a rotary evaporator and then redissolved with methanol to obtain the AZA-2 standard substance.
